Learn How PCF Research Saves Men's Lives
BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).
Home
Learn More
Learn More
PCF’s new President and CEO is an optimist with big plans for reducing deaths, prolonging lives, and dramatically improving quality of life for patients with prostate cancer.
Read MoreThe Prostate Cancer Foundation is excited to announce a new series of webinars hosted by Charles J. Ryan, MD, PCF President and CEO. PCF aims to connect patients and caregivers with current, essential information across the various stages of the prostate cancer journey. Each month, Dr. Ryan will speak with leaders in the field of prostate cancer diagnosis, treatment, research, and survivorship and answer your questions during these live virtual events.
Read MoreNew programming is a collaboration between NYU Langone Health’s Perlmutter Cancer Center and the Prostate Cancer Foundation to address prostate health, cancer prevention and screening, research, and more.
Read MorePCF acquired Digital Science Press, Inc., (DSP) digital publisher of UroToday.com and a global leader in providing evidence-based clinical content and educational resources within the fields of urology and genitourinary oncology. With the acquisition, DSP founder and CEO Gina Carithers joins PCF as chief communications officer (CCO).
Read MoreJoin the September Get Healthy run/walk challenge in honor of Prostate Cancer Awareness Month. Can you complete 108 miles in 30 days for the 1 in 8 men that will be diagnosed with prostate cancer in their lifetime? This September, challenge yourself to raise money for prostate cancer research AND walk away with better health.
LEARN MOREJoin the September Get Healthy eating challenge in honor of Prostate Cancer Awareness Month. Whether you are a patient with prostate cancer, a caregiver, an amateur chef, or just someone who needs inspiration to eat healthy, this challenge is for you.
LEARN MOREWhen Dr. Robert Hollander was diagnosed with prostate cancer, he wanted to channel his passion for winemaking to support prostate cancer research. He is now preparing...
We are in a race for patients. For your husbands and fathers. For your sons ... and now your daughters.
A PCF-funded study published in the prestigious journal Science has identified a new subtype of castration-resistant prostate cancer (CRPC). Understanding how genes and proteins “drive” this particular type of cancer may lead to new treatments. In...
Advanced Prostate CancerFrom the Lab“Plant-based” foods are increasingly on the radar. You can grab a green juice at most chain coffee shops, a decent salad at airport restaurants, or a meat-free veggie burger at some locations of the major burger...
DietNutritionAs men age, their testosterone levels can fall: by one estimate, 39% of men aged 45-85 have blood testosterone levels considered low (less than 300 ng/mL). Many have no symptoms, but some men may experience symptoms...
Questions for Your Treatment TeamSexual Health“I don’t think we’ve ever been in a more exciting time in prostate cancer and oncology, with advances in targeted therapies, hormonal therapies, cellular therapies, radioligand therapies. We don’t know what’s the next big thing, but...
PCFPCF PerspectiveReceive PCF news in your inbox
.
If you’ve recently been diagnosed with prostate cancer, you may be asking yourself if there were warning signs or symptoms you should have noticed earlier. So...
In 1993, PCF created a Competitive Awards program that revolutionized the evaluation and funding of prostate cancer research. Fortune magazine credited PCF with creating the “modern venture philanthropy” model for cancer research—citing the transformative power of PCF’s short grant applications and rapid funding. The awards empowered many young scientists to fill the pipeline...
For ResearchersThe Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has been responsible for raising close to $1 billion in support of cutting-edge research by more than 2,200 research projects at 245 leading cancer centers in 28 countries around the world. Since PCF’s inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to creating a global public square for prostate cancer, in service to our mission of ending death and suffering from the disease.
Learn more about our foundation